Novavax Clinical Trial / Is Novavax's Growth Story Over? | The Motley Fool : Novavax inc said on monday it has started the phase 1 clinical trial of a novel coronavirus vaccine candidate and has enrolled the trial's first participants, with preliminary results slated for july.
Novavax Clinical Trial / Is Novavax's Growth Story Over? | The Motley Fool : Novavax inc said on monday it has started the phase 1 clinical trial of a novel coronavirus vaccine candidate and has enrolled the trial's first participants, with preliminary results slated for july. . Novavax is also currently conducting a phase 3 clinical study in the united kingdom, a phase 2b trial in south africa and a phase 1/2 continuation in the us and australia, data from which are expected. The trial design is harmonized with those of other leading companies. Researchers analyze clinical trial data at predetermined points during the study. Novavax is leading the trial as the regulatory sponsor. The novavax coronavirus vaccine could submit its results to the uk regulator within two weeks, says the clinical trial chief, with supplies set to be available to britain as soon as this summer. The novavax coronavirus vaccine could submit its results to the uk regulator within two
